WallStreetZenWallStreetZen

NASDAQ: ESLA
Estrella Immunopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Estrella Immunopharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, ESLA annual revenue was $0.0, with N/A growth year-over-year.

ESLA revenue history

Current Revenue
$0.0
Current Earnings
-$8.8M
Current Profit Margin
0%

Be the first to know when ESLA announces revenue.

ESLA Revenue History By Year

ESLA Yearly RevenueESLA RevenueESLA ChangeESLA Revenue Growth
2024-06-30$0.00N/AN/A
2023-06-30$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-06-30$0.00N/AN/A

1 of 1

Estrella Immunopharma Revenue FAQ

What was ESLA's revenue last quarter?

Estrella Immunopharma (NASDAQ: ESLA) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Estrella Immunopharma's revenue was $0.00.

What was Estrella Immunopharma's revenue in 2024?

Estrella Immunopharma's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.

How much does Estrella Immunopharma make in a day?

Based on Estrella Immunopharma annual revenue for the past three years, ESLA makes an average of $0.00 per day.

What was Estrella Immunopharma's annual revenue growth in the past year?

As of Q2 2025, Estrella Immunopharma's revenue has grown null year over year. Estrella Immunopharma's revenue in the past year totaled $0.00.

How much does Estrella Immunopharma make in a year?

Estrella Immunopharma's revenue by year for the past three years is:
  • Estrella Immunopharma's revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.
  • Estrella Immunopharma's annual revenue for Jun 30, 2023 was $0.00, a N/A decrease from 2022.
  • Estrella Immunopharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.